# A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989

> **NCT04208386** · PHASE1 · COMPLETED · sponsor: **Janssen Sciences Ireland UC** · enrollment: 16 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** JNJ-73763989

## Key facts

- **NCT ID:** NCT04208386
- **Lead sponsor:** Janssen Sciences Ireland UC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-08
- **Primary completion:** 2020-07-20
- **Final completion:** 2020-07-20
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04208386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04208386, "A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04208386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*